Top Updates Back
CSL Behring
CSL Behring's Parent Company Alias
CSL (CSL Behring's Parent Company) Alias
Australia
Immunology
Hematology
Cardiovascular and Metabolic
Respiratory
Transplant
Plasma Fractionation
Recombinant Protein Technology
Cell and Gene Therapy
Development and delivery of innovative medicines for bleeding disorders
Treatment of immune deficiencies
Treatment of chronic inflammatory demyelinating polyneuropathy
Treatment of hereditary angioedema
Treatment of Alpha 1 Antitrypsin Deficiency
Biotherapy products for rare diseases
Melbourne, Australia
32,000 people
Company name
Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
CSL Seqirus
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
CSL Vifor
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary

2 entries
DateDescription
2023-04-07 Staff who work at the CSL Behring location were first to donate during the soft opening.
2023-04-10 The new center will open to the public April 10 and has been outfitted with new donation technology designed for quicker collection times.
+ Loaded when opened
✅
2026-09-21 18:11 (Model: ggml-org/gpt-oss-20b )
↑